DISEASE CHARACTERISTICS:

• Histologically confirmed Hodgkin's lymphoma, non-Hodgkin's lymphoma, or lymphoid leukemia with at least 10% of malignant cells reacting with anti-Tac monoclonal antibody (waived for Hodgkin's lymphoma)

  • Hodgkin's lymphoma meeting the following criteria:

    • Stages II-IV that relapsed or failed to achieve complete remission after first line chemotherapy, and not eligible for or refused salvage chemotherapy or bone marrow transplantation

PATIENT CHARACTERISTICS:

Age:

• 18 and over

Performance status:

• Karnofsky 50-100%

Life expectancy:

• Greater than 1 month

Hematopoietic:

• Granulocyte count at least 1,200/mm^3
• Platelet count greater than 100,000/mm^3

Hepatic:

• SGOT and SGPT less than 5 times upper limit of normal (ULN)
• Bilirubin less than 3 times ULN

Renal:

• Creatinine less than 2.0 mg/dL OR
• Creatinine clearance greater than 50 mL/min

Cardiovascular:

• No clinical evidence of cardiac failure

Pulmonary:

• No symptomatic pulmonary dysfunction unless due to malignancy

Other:

• Not pregnant or nursing
• Negative pregnancy test
• HIV negative
• No active second primary malignancy other than basal cell skin cancer
• No symptomatic disease due to CNS involvement

PRIOR CONCURRENT THERAPY:

Biologic therapy:

• No anticoagulant therapy

Chemotherapy:

• At least 3 weeks since prior chemotherapy
• No concurrent chemotherapy

Endocrine therapy:

• Corticosteroids allowed if dose is stable for at least 3 weeks

Radiotherapy:

• At least 3 weeks since prior radiotherapy
• No concurrent radiotherapy

Surgery:

• Not specified